| Functional mechanism and clinical implications of LINC00339 in delayed fracture healing. | Functional mechanism and clinical implications of LINC00339 in delayed fracture healing.
Li Y, Sun Y, Ma K, Wang S, Wang Z, Huang L., Free PMC Article | 10/7/2024 |
| LINC00339 accelerates invasion and migration of colorectal cancer via mediating miRNA-30a-5p. | LINC00339 accelerates invasion and migration of colorectal cancer via mediating miRNA-30a-5p.
Zhou P, Wu J, Zheng Z, Liao C, Sun X. | 02/2/2024 |
| LINC00339: An emerging major player in cancer and metabolic diseases. | LINC00339: An emerging major player in cancer and metabolic diseases.
Wu Z, Zhang S, Guo W, He Y. | 04/30/2022 |
| Elucidating the role of long intergenic non-coding RNA 339 in human endometrium and endometriosis. | Elucidating the role of long intergenic non-coding RNA 339 in human endometrium and endometriosis.
Holdsworth-Carson SJ, Churchill M, Donoghue JF, Mortlock S, Fung JN, Sloggett C, Chung J, Cann L, Teh WT, Campbell KR, Luwor R, Healey M, Montgomery G, Girling JE, Rogers PAW. | 11/27/2021 |
| CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis. | CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.
Jiang X, Liu J, Li S, Jia B, Huang Z, Shen J, Luo H, Zhao J., Free PMC Article | 05/15/2021 |
| Avasimibe inhibits the proliferation, migration and invasion of glioma cells by suppressing linc00339. | Avasimibe inhibits the proliferation, migration and invasion of glioma cells by suppressing linc00339.
Luo Y, Liu L, Li X, Shi Y. | 02/27/2021 |
| LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma. | LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
Chen K, Zhang L. | 08/29/2020 |
| LINC00339 regulated ovarian cancer cell proliferation, migration, and invasion by targeting miR-148a-3p/ROCK1 pathway. | LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes.
Pan L, Meng Q, Li H, Liang K, Li B. | 04/25/2020 |
| LINC00339 was markedly over-expressed in pancreatic cancer (PANC) tissues and cells and promoted cell proliferation, invasion, and migration via sponging miR-497-5p, thereby increasing IGF1R expression. Our study could provide a novel target for PANC diagnosis and biotherapy. | LINC00339 promotes cell proliferation and metastasis in pancreatic cancer via miR-497-5p/IGF1R axis.
Zhang R, Hao S, Yang L, Xie J, Chen S, Gu G. | 11/23/2019 |
| LINC00339 promotes proliferation, and suppresses apoptosis of colorectal cancer cells via downregulating miR-218 | [The expression and functional mechanism of long non-coding RNA LINC00339 in colorectal cancer].
Fu Q, Cheng J, Zhang JD, Zhang YL, Chen XB, Xie JG, Luo SX. | 07/13/2019 |
| Downregulation of LINC00339 significantly increases the expression of CDC42 in osteoblast cells, which is a pivotal regulator involved in bone metabolism. | An Osteoporosis Risk SNP at 1p36.12 Acts as an Allele-Specific Enhancer to Modulate LINC00339 Expression via Long-Range Loop Formation.
Chen XF, Zhu DL, Yang M, Hu WX, Duan YY, Lu BJ, Rong Y, Dong SS, Hao RH, Chen JB, Chen YX, Yao S, Thynn HN, Guo Y, Yang TL., Free PMC Article | 12/22/2018 |
| Results showed that LINC00339 was significantly up-regulated in NSCLC tissue and cells, which indicated the poor prognosis of NSCLC patients. | Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1.
Yuan Y, Haiying G, Zhuo L, Ying L, Xin H. | 11/17/2018 |
| Chromatin conformation capture provides evidence for risk SNPs interacting with the promoters of both LINC00339 and CDC4 and luciferase reporter assays suggest the risk SNP rs12038474 is located in a transcriptional silencer for CDC42 and the risk allele increases expression of CDC42. | Endometriosis risk alleles at 1p36.12 act through inverse regulation of CDC42 and LINC00339.
Powell JE, Fung JN, Shakhbazov K, Sapkota Y, Cloonan N, Hemani G, Hillman KM, Kaufmann S, Luong HT, Bowdler L, Painter JN, Holdsworth-Carson SJ, Visscher PM, Dinger ME, Healey M, Nyholt DR, French JD, Edwards SL, Rogers PA, Montgomery GW. | 02/17/2018 |